Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more
Market Cap & Net Worth: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (SHE:000766) has a market capitalization of $2.77 Billion (CN¥20.33 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #4946 globally and #577 in its home market, demonstrating a -1.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's stock price CN¥21.03 by its total outstanding shares 966494707 (966.49 Million).
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Market Cap History: 2015 to 2026
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $2.21 Billion to $2.77 Billion (6.71% CAGR).
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.56x
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's market cap is 1.56 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
36.64x
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's market cap is 36.64 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.21 Billion | $197.56 Million | $6.86 Million | 11.16x | 321.29x |
| 2016 | $2.31 Billion | $850.08 Million | $213.46 Million | 2.72x | 10.84x |
| 2017 | $1.79 Billion | $1.52 Billion | $257.88 Million | 1.18x | 6.95x |
| 2018 | $903.63 Million | $2.09 Billion | $330.86 Million | 0.43x | 2.73x |
| 2019 | $861.48 Million | $1.98 Billion | -$2.04 Billion | 0.44x | N/A |
| 2020 | $429.42 Million | $1.11 Billion | -$359.50 Million | 0.39x | N/A |
| 2021 | $625.69 Million | $1.52 Billion | $35.27 Million | 0.41x | 17.74x |
| 2022 | $694.19 Million | $1.47 Billion | $30.15 Million | 0.47x | 23.02x |
| 2023 | $2.63 Billion | $1.47 Billion | $43.93 Million | 1.78x | 59.79x |
| 2024 | $2.07 Billion | $1.32 Billion | $56.44 Million | 1.56x | 36.64x |
Competitor Companies of 000766 by Market Capitalization
Companies near Tonghua Golden-Horse Pharmaceutical Industry Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Tonghua Golden-Horse Pharmaceutical Industry Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's market cap moved from $2.21 Billion to $ 2.77 Billion, with a yearly change of 6.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.77 Billion | -23.50% |
| 2025 | CN¥3.62 Billion | +75.10% |
| 2024 | CN¥2.07 Billion | -21.26% |
| 2023 | CN¥2.63 Billion | +278.37% |
| 2022 | CN¥694.19 Million | +10.95% |
| 2021 | CN¥625.69 Million | +45.71% |
| 2020 | CN¥429.42 Million | -50.15% |
| 2019 | CN¥861.48 Million | -4.66% |
| 2018 | CN¥903.63 Million | -49.56% |
| 2017 | CN¥1.79 Billion | -22.55% |
| 2016 | CN¥2.31 Billion | +4.90% |
| 2015 | CN¥2.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.77 Billion USD |
| MoneyControl | $2.77 Billion USD |
| MarketWatch | $2.77 Billion USD |
| marketcap.company | $2.77 Billion USD |
| Reuters | $2.77 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.